Company intelligence / Profile preview

Alerion Biomedical

San Diego, California, United States

Ownership: Private
Development stage: Other

Overview

Alerion Biomedical developed the Fenestra product line for revolutionizing in vivo imaging in basic research and drug development. The company's imaging technology and product assets were acquired by Advanced Research Technologies Inc. in March 2006.

Therapeutic areas: CardiovascularGastroenterologyOncology
Modalities: DeviceBiologic
Industry: Medical Imaging

Partnerships

California Institute of TechnologyResearch Corporation Technologies

Beyond the preview

Go deeper on Alerion Biomedical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Alerion Biomedical.

Explore the full profile